Diagnosis of Acute Rheumatic Fever in an 8-Year-Old Child: A Case Report
DOI:
https://doi.org/10.29303/jk.v15i1.8359Keywords:
Demam Rematik Akut, Streptococcus, Jones Criteria, Migratory Arthritis, Rheumatic Heart Disease.Abstract
Abstract: Acute Rheumatic Fever (ARF) is a serious autoimmune disease caused by a Group A Streptococcus (GAS) infection. In genetically susceptible people, the immune system mistakenly attacks its own tissues, a process called molecular mimicry. This can lead to inflammation of the joints and permanent heart valve damage, known as Rheumatic Heart Disease (RHD). Diagnosing ARF is challenging as symptoms are varied and there is no single test. A diagnosis relies on the Jones Criteria, which combine clinical signs with evidence of a prior GAS infection.
Case Illustration : An 8-year-old boy presented with migratory arthritis in his hands and feet, following a week of a sore throat and intermittent fever. Residing in a densely populated area, the patient had an environmental risk factor for bacterial spread. Lab tests confirmed a preceding Streptococcus infection with an elevated anti-streptolysin O (ASTO) titer of 800 IU/mL and a C-Reactive Protein (CRP) level of 41 mg/L. The diagnosis of Acute Rheumatic Fever was established, as the patient met one major criterion (arthritis) and two minor criteria (fever and elevated CRP) based on the Jones Criteria.
Conclusion : An 8-year-old boy was diagnosed with Acute Rheumatic Fever (ARF), an autoimmune disease triggered by a Group A beta-hemolytic Streptococcus infection. The main symptoms were migratory arthritis and intermittent fever, preceded by a sore throat. The diagnosis was confirmed using the Jones Criteria, as the patient met one major criterion (arthritis) and two minor criteria (fever and elevated C-Reactive Protein or CRP). Evidence of the prior infection was supported by an increased anti-streptolysin O (ASTO) titer of 800 IU/mL.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Fitri Nazilinly, dr. Yudhi Kurniawan, Sp. A (K)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.
